Stiff-person syndrome treated with rituximab
- PMID: 22802263
- PMCID: PMC3029087
- DOI: 10.1136/bcr.05.2010.3021
Stiff-person syndrome treated with rituximab
Abstract
Stiff-person syndrome (SPS) is a rare neurological condition consisting of progressive and fluctuating rigidity of the axial muscles combined with painful spasms. The pathophysiology of SPS is not fully understood, but there seems to be an autoimmune component. The use of rituximab, a chimeric monoclonal antibody targeting CD20 protein in the surface of mature B cells, for the treatment of SPS is a recent therapeutical approach showing promising results. The authors present a case report of a 41-year-old female patient diagnosed with SPS who was treated with rituximab in a public hospital in Brasília, Brazil, showing a good and safe response to the treatment so far. Our data go along with some recent articles published in the literature.
Conflict of interest statement
Figures



References
-
- Snow BJ, Tsui JKC, Bhatt MH, et al. Treatment of spasticity with botulinum toxin: a doubleblind study. Ann Neurol 1990;28:512–15 - PubMed
-
- Rodgers-Neame N. Stiff Person Syndrome, 2009. http://emedicine.medscape.com/article/1172135-overview (accessed 10 Sep 2009)
-
- Cabo-López I, Negueruela-López M, Garcia-Bermejo P, et al. Síndrome de la persona rígida: a propósito de un caso. Rev Neurol 2008;47:249–52 - PubMed
-
- Liguori R, Cordivari C, Lugaresi E, et al. Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome. Mov Disord 1997;12:1060–3 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources